Activities
|
03/23/2023
On March 13, 2023, the Platform for Research and Inspiration in Regulatory Science hosted the "Keynote Speech of Lawyer Chia-Feng Lu (呂家鋒)". Lawyer Chia-Feng Lu, currently a shareholder at Greenberg Traurig Law Offices in Washington, DC & Tokyo, participated in two important bills that have greatly impacted the pharmaceutical industry: the Food and Drug Omnibus Reform Act (FDORA) and the Inflation Reduction Act (IRA). Lawyer Lu provided insights and highlighted the latest changes in US FDA policies. The US drug pricing reform will prompt stakeholders to adjust assets and strategies, changing drug markets. Attendance at the event will aid Taiwan's pharmaceutical industry in comprehending the practical impact of these bills on licensing, investment, and biotechnology. This knowledge will assist the industry in drug development and international market connections to tackle future challenges in the biopharmaceutical sector.
於2023年3月13日，國際藥政法規科學研究平台邀請呂家鋒律師進行專題演講。呂家鋒律師現為Greenberg Traurig律師事務所華盛頓特區與東京辦公室資深合夥人，在華府參與了兩項對製藥產業界影響重大法案：使用者付費法案(Food and Drug Omnibus Reform Act, FDORA)和降低通膨法案(Inflation Reduction Act, IRA)的協商。呂律師在本次專題演講分享了美國FDA法案背景與政策的最新變革，美國藥品定價制度的改革措施將重新定義產品商業上市的格局，促使利益相關者調整資產評估與企業策略，透過此次演講使國內製藥產業界深入了解這兩項法案在生技醫藥授權談判和投資策略的實際影響，協助臺灣因應未來生技製藥挑戰的藥品研發對策的制訂與接軌國際市場商業的規劃。
Speech photos
活動剪影
